Thorsten Raff

5.4k total citations
32 papers, 2.6k citations indexed

About

Thorsten Raff is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Thorsten Raff has authored 32 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 13 papers in Public Health, Environmental and Occupational Health and 11 papers in Hematology. Recurrent topics in Thorsten Raff's work include Lymphoma Diagnosis and Treatment (18 papers), Acute Lymphoblastic Leukemia research (13 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Thorsten Raff is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Acute Lymphoblastic Leukemia research (13 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Thorsten Raff collaborates with scholars based in Germany, Netherlands and United States. Thorsten Raff's co-authors include Monika Brüggemann, Michael Kneba, Matthias Ritgen, Nicola Gökbuget, Dieter Hoelzer, Christiane Pott, Eckhard Thiel, Silke Lüschen, Heinz‐August Horst and Vincent H. J. van der Velden and has published in prestigious journals such as Blood, The Journal of Pathology and Journal of Immunological Methods.

In The Last Decade

Thorsten Raff

32 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thorsten Raff Germany	19	1.5k	1.3k	853	620	592	32	2.6k
Richard Ratei Germany	31	1.7k 1.2×	1.5k 1.1×	376 0.4×	572 0.9×	361 0.6×	60	2.7k
Cornelia Eckert Germany	29	1.8k 1.3×	1.5k 1.1×	404 0.5×	655 1.1×	330 0.6×	84	2.9k
FG Behm United States	36	2.2k 1.5×	2.1k 1.6×	386 0.5×	538 0.9×	494 0.8×	65	3.4k
H. Diedrich Germany	19	1.6k 1.1×	1.4k 1.1×	457 0.5×	1.3k 2.0×	345 0.6×	34	2.8k
Susanne Viehmann Germany	21	1.3k 0.9×	1.6k 1.2×	312 0.4×	325 0.5×	526 0.9×	33	2.6k
F G Behm United States	30	2.1k 1.4×	2.0k 1.5×	320 0.4×	403 0.7×	499 0.8×	53	3.2k
A Parreira Portugal	19	805 0.6×	1.4k 1.0×	532 0.6×	343 0.6×	678 1.1×	40	2.2k
DJ Pullen United States	34	3.2k 2.2×	2.6k 2.0×	519 0.6×	511 0.8×	522 0.9×	75	4.0k
Jan Trka Czechia	34	2.0k 1.3×	2.1k 1.6×	446 0.5×	452 0.7×	449 0.8×	149	3.7k
Mårina Lafage‐Pochitaloff France	29	1.1k 0.8×	2.2k 1.7×	285 0.3×	723 1.2×	586 1.0×	76	3.7k

Countries citing papers authored by Thorsten Raff

Since Specialization

Citations

This map shows the geographic impact of Thorsten Raff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Raff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Raff more than expected).

Fields of papers citing papers by Thorsten Raff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten Raff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Raff. The network helps show where Thorsten Raff may publish in the future.

Co-authorship network of co-authors of Thorsten Raff

This figure shows the co-authorship network connecting the top 25 collaborators of Thorsten Raff. A scholar is included among the top collaborators of Thorsten Raff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thorsten Raff. Thorsten Raff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Neumann, Martín, Sandra Heesch, Cornelia Schlee, et al.. (2013). Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. Blood. 121(23). 4749–4752. 143 indexed citations

Günther, Andreas, Roland Repp, Andreas Humpe, et al.. (2013). Allogeneic Stem Cell Transplantation with BEAM and Alemtuzumab Conditioning Immediately after Remission Induction Has Curative Potential in Advanced T-Cell Non-Hodgkin's Lymphoma. Biology of Blood and Marrow Transplantation. 19(11). 1632–1637. 17 indexed citations

Raff, Thorsten, Antonis Dagklis, Tatjana Smilevska, et al.. (2011). Partial versus Productive Immunoglobulin Heavy Locus Rearrangements in Chronic Lymphocytic Leukemia: Implications for B-Cell Receptor Stereotypy. Molecular Medicine. 18(1). 138–145. 9 indexed citations

Böttcher, Sebastian, Stephan Stilgenbauer, Robert Busch, et al.. (2009). Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis. Leukemia. 23(11). 2007–2017. 73 indexed citations

Velden, Vincent H. J. van der, Giovanni Cazzaniga, André Schrauder, et al.. (2007). Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia. 21(4). 604–611. 464 indexed citations

Raff, Thorsten, Nicola Gökbuget, Silke Lüschen, et al.. (2006). Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials. Blood. 109(3). 910–915. 179 indexed citations

Pott, Christiane, Sebastian Böettcher, Monika Brüggemann, et al.. (2006). Quantitative Assessment of Circulating t(14;18) Positive Cells by RQ-PCR at Diagnosis and Follow-Up Correspond to Clinical Characteristics and Predicts Time to Treatment Failure in Follicular Lymphoma.. Blood. 108(11). 2414–2414. 3 indexed citations

Pott, Christiane, Carsten Schrader, Monika Brüggemann, et al.. (2005). Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease. European Journal Of Haematology. 74(4). 353–358. 17 indexed citations

Brüggemann, Monika, Thorsten Raff, Thomas Flohr, et al.. (2005). Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood. 107(3). 1116–1123. 388 indexed citations

10.

Böttcher, Sebastian, Matthias Ritgen, Monika Brüggemann, et al.. (2005). Flow cytometric assay for determination of FcγRIIIA-158 V/F polymorphism. Journal of Immunological Methods. 306(1-2). 128–136. 20 indexed citations

11.

Velden, Vincent H. J. van der, Monika Brüggemann, Patricia G. Hoogeveen, et al.. (2004). TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse. Leukemia. 18(12). 1971–1980. 35 indexed citations

12.

Brüggemann, Monika, Vincent H. J. van der Velden, Thorsten Raff, et al.. (2004). Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia. Leukemia. 18(4). 709–719. 64 indexed citations

13.

Böttcher, Sebastian, Matthias Ritgen, Christiane Pott, et al.. (2004). Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation. Leukemia. 18(10). 1637–1645. 67 indexed citations

14.

Szczepański, Tomasz, Vincent H. J. van der Velden, Thorsten Raff, et al.. (2003). Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL. Leukemia. 17(11). 2149–2156. 57 indexed citations

15.

Heinemann, Klaas, Christine Thiel, Sabine Möhner, et al.. (2003). Benign gynecological tumors: estimated incidence. European Journal of Obstetrics & Gynecology and Reproductive Biology. 107(1). 78–80. 24 indexed citations

16.

Heinemann, Lothar, et al.. (2003). Use of Oral Contraceptives and Risk of Cancer of the Uterine Corpus or Ovary. Two Case-Control Studies. Geburtshilfe und Frauenheilkunde. 63(10). 1018–1026. 3 indexed citations

17.

Gökbuget, Nicola, Michael Kneba, Thorsten Raff, et al.. (2002). Risk-adapted treatment according to minimal residual disease in adult ALL. Best Practice & Research Clinical Haematology. 15(4). 639–652. 14 indexed citations

18.

Jäckel, Renate, et al.. (2002). Toxisch epidermale Nekrolyse. Der Anaesthesist. 51(10). 815–819. 7 indexed citations

19.

Herbst, Hermann, et al.. (1997). Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. The Journal of Pathology. 182(3). 299–306. 38 indexed citations

20.

Herbst, Hermann, Thorsten Raff, & Harald Stein. (1996). PHENOTYPIC MODULATION OF HODGKIN AND REED-STERNBERG CELLS BY EPSTEIN-BARR VIRUS. The Journal of Pathology. 179(1). 54–59. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact